| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 604058000 | Powder dispenser | 19 |
| 20080262417 | NEEDLELESS SYRINGE - The invention provides a device which seeks to ensure that substantially all the particles delivered avoid interaction with the so-called “starting process”. There is provided a needleless injection device comprising a driver chamber ( | 10-23-2008 |
| 20090281486 | APPARATUS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS - The present embodiments provide apparatus and methods suitable for delivering a therapeutic agent to a target site. The apparatus generally comprises at least one container for holding a therapeutic agent, and a pressure source for facilitating delivery of the therapeutic agent. In one embodiment, the pressure source may be placed in selective fluid communication with a proximal region of the container and fluid from the pressure source may flow through at least a portion of the container to urge the therapeutic agent through container towards the target site. In an alternative embodiment, the container and the pressure source may be coupled to first and second inlet ports of a connecting member, respectively, such that the therapeutic agent flows through an outlet port of the connecting member and towards the target site. | 11-12-2009 |
| 20090281487 | BIOPOLYMER POWDER GELATING/JETTING APPARATUS - A system is provided for efficiently gelating and injecting a constant amount of biopolymer powder for effectively using biopolymer in sealing, stanching, and prevention of adhesion of a post-surgical site. Powder transfer line | 11-12-2009 |
| 20100121261 | Anti-Adhesion Spraying - Dry powders containing bioresorbable hyaluraonic acid (“HA”) are applied directly to a desired location in a patient wound to reduce adhesions, without first forming a hydrated gel. HA includes hyaluronic acid that has been modified, cross-linked or combined with other substances. it is important to control the size of the particles in the powder. The powder is essentially dry and blowable powder. At least 90% of powder particles have a maximum dimension between 30 μm and 1 mm. | 05-13-2010 |
| 20100211001 | BIOPOLYMER POWDER GELATING/JETTING APPARATUS - A system is provided for efficiently gelating and injecting a constant amount of biopolymer powder for effectively using biopolymer in sealing, stanching, and prevention of adhesion of a post-surgical site. Powder transfer line | 08-19-2010 |
| 20120010561 | MEDICINAL IMPLANT DEVICE AND CARTRIDGE - The invention includes a device for inserting a medicament within a body cavity of a mammal, and a cartridge for containing the medicament within the device, where the cartridge includes a housing, a retractable chamber for containing medicament disposed within the housing, and a substantially stationary member disposed within the barrel of the retractable chamber, where upon activation of the device, the retractable chamber is retracted about the substantially stationary member, thereby depositing medicament within the body cavity. | 01-12-2012 |
| 20120116296 | SYSTEMS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS - The present embodiments provide systems and methods suitable for delivering a therapeutic agent to a target site. The systems generally comprise a container for holding a therapeutic agent, and a pressure source configured to be placed in selective fluid communication with at least a portion of a reservoir of the container. In one embodiment, fluid from the pressure source is directed through a first region of the container in a direction towards a second region of the container. The fluid then is at least partially redirected to urge the therapeutic agent in a direction from the second region of the container towards the first region of the container and subsequently towards the target site. In alternative embodiments, the fluid from the pressure source may be directed through the second region of the container in a direction towards the first region of the container. | 05-10-2012 |
| 20120259277 | MEDICAL DEVICES FOR DISPENSING POWDERS - A medical device for topical, intranasal or oral administration of dry powder medical compositions includes a unit dose blister form containing an internal piercing device that provides for agitation, dispersion and dispensation of the powder to a user. | 10-11-2012 |
| 20120310151 | WIRELESS MICROACTUATORS AND CONTROL METHODS - Embodiments of the present technology include a micromachined implantable drug delivery devices, grippers, and syringes that are wirelessly powered and controlled by frequency tuning of external radiofrequency (RF) magnetic fields. An illustrative device can be designed and constructed with passive circuitry and microvalves that operate without batteries, e.g., through thermal actuation of hydrogel microvalves and/or shape-memory alloy members. The frequency selectivity in the device control provides not only a path to achieving reliable and safe operation of drug delivery but also potential applications for selective delivery of multiple drugs. | 12-06-2012 |
| 20130066262 | MULTI-DOSE DELIVERY SYSTEM - According to some embodiments, an apparatus may deliver a medication that comprises a multi-dose syringe, a multi-dose medication storage unit coupled to the multi-dose syringe, and a trigger mechanism. The multi-dose medication storage is to comprise a plurality of pre-loaded doses of a medication where the medication is in powder form. Moreover, the trigger mechanism is to facilitate delivery of one or more of the plurality of doses of the medication from the multi-dose medication storage unit. | 03-14-2013 |
| 20130096493 | SPRAYING DEVICE - An administration device can discharge a prescribed, equal amount of medicine a number of times by spraying. A spraying device includes a barrel; a gasket provided slidably movable in liquid-tight manner in the barrel; a rod coupled to a base end of the gasket; and a regulating member provided on the barrel, having a projection that can slidably fit with the guide groove. The guide groove includes at least first and second continuous administering grooves. The second administering groove is configured to include a transitional portion extending in the circumferential direction with a groove wall on the base end side aligned with the base end of the first administering portion, and a second administering portion extending from the transitional portion to a base end along the longitudinal direction. An energizing protrusion engageable with the projection is provided at a boundary between the transitional portion and the second administering portion. | 04-18-2013 |
| 20130218072 | POWDER SPRAYING DEVICE - The invention is configured so that pressurized gas from a pressurized gas supply source passes through a pressurized gas channel provided in a main body of a powder spraying device and is sprayed out. A powder container containing powder such as medical agents is provided on the main body. The powder within the powder container is supplied to the pressurized gas channel and is sprayed together with the pressurized gas. An eccentric rotor with a center of gravity deviated from a center of rotation is provided in the main body. When spraying the powder together with the pressurized gas, vibrations are applied to the main body and the powder container by a rotation of the eccentric rotor. The powder can be thereby mixed more evenly with the pressurized gas. | 08-22-2013 |
| 20140018729 | BIOMEDICAL HAEMOSTATIC POWDER DISPENSER - A biomedical haemostatic powder dispenser ( | 01-16-2014 |
| 20140288491 | Composition for the Treatment of Fistula - A composition for use in the treatment of fistula, the composition comprising activated carbon. | 09-25-2014 |
| 20150094649 | THERAPEUTIC AGENTS FOR DELIVERY USING A CATHETER AND PRESSURE SOURCE - The present embodiments provide systems and methods suitable for delivering a therapeutic agent to a target site. A container holds the therapeutic agent and a pressure source has pressurized fluid in selective fluid communication with at least a portion of the container. A catheter, in fluid communication with the container, has a lumen sized for delivery of the therapeutic agent to a target site. In one embodiment, a diameter of particles of the therapeutic agent is in a range of between about 1 micron to about 925 microns, a mass of the particles of the therapeutic agent is in a range of between about 0.0001 mg to about 0.5 mg, a ratio of an inner diameter of the catheter to the diameter of particles is at least 4:1, and a regulated pressure of the pressurized fluid is between about 0.01 psi to about 100 psi. | 04-02-2015 |
| 20150112251 | Positionable Delivery Device and Method - A cartridge for delivery of a material therefrom which has a corrugated portion to allow for bending/extending to be applied to the device from which a material to be deposited can be dispensed. The bendability and extendibility allow for greater efficiency in use and application of the material into cavities, pockets, and/or crevices where one needs to deposit the material. | 04-23-2015 |
| 20150306317 | SYSTEMS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS - The present embodiments provide systems and methods suitable for delivering a therapeutic agent to a target site. The systems generally comprise a container having first and second regions and a reservoir containing the therapeutic agent. A pressure source having pressurized fluid is in selective fluid communication with at least a portion of the reservoir. An outlet tube is in fluid communication with the reservoir of the container. At least one slot is formed in a lateral surface of the outlet tube at a position between first and second ends of the outlet tube. | 10-29-2015 |
| 20160022911 | DEVICES AND METHODS FOR DELIVERING PARTICLES - Systems, devices, and methods for delivering therapeutic particles are disclosed. In one variation, a device for delivering particles includes a gas supply configured for supplying gas under pressure, a particle cassette comprising the particles, a cassette housing, and a cassette membrane. The cassette housing can comprise an Ethylene Vinyl Acetate (EVA) copolymer of 18% to 28% by weight of Vinyl Acetate (VA). The device can also include a safety interlock to prevent or minimize the risk that the device will be unintentionally activated. The device can also have a silencer. | 01-28-2016 |
| 20160175495 | Medical Devices for Local Bioactive Delivery | 06-23-2016 |
